Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.11604/pamj.supp.2020.35.134.25011 http://scihub22266oqcxt.onion/10.11604/pamj.supp.2020.35.134.25011 33193949!7608760!33193949     free     free     free Warning: file_get_contents(https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=33193949&cmd=llinks): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 215       Pan+Afr+Med+J 2020 ; 35 (Suppl 2): 134 Nephropedia Template TP {{tp|p=33193949|t=2020. Une infection par le SARS-CoV-2 chez un patient sous hydroxychloroquine et anti TNF alpha pour rhumatisme inflammatoire chronique |pdf=|usr=}}{{33193949}} gab.com Text Une infection par le SARS-CoV-2 chez un patient sous hydroxychloroquine et anti TNF alpha pour rhumatisme inflammatoire chronique JO: Pan Afr Med J http://www.kidney.de/pget.php?&tw=1&pmid=33193949 #FOAvip Hydroxychloroquine is an agent used as a treatment but also considered as a prophylaxis for SARS-CoV-2 infection. We report the case of a patient who developed COVID-19 while on hydroxychloroquine for mixed connectivitis associated with spondyloarthritis. Although more work is needed before any conclusions can be drawn, this raises questions about the protective role of this drug against infection. Are they really protected against COVID-19 or will they develop pauci-symptomatic forms? Twit Text FOAVip Une infection par le SARS-CoV-2 chez un patient sous hydroxychloroquine et anti TNF alpha pour rhumatisme inflammatoire chronique ????Pan Afr Med J http://www.kidney.de/pget.php?&tw=1&pmid=33193949 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=33193949 #FOAvip English Wikipedia <ref>{{Cite pmid|33193949}}</ref> Une infection par le SARS-CoV-2 chez un patient sous hydroxychloroquine et anti TNF alpha pour rhumatisme inflammatoire chronique #MMPMID33193949 Malek SA; Bouchti IE Pan Afr Med J 2020[]; 35 (Suppl 2): 134 PMID33193949show ga Hydroxychloroquine is an agent used as a treatment but also considered as a prophylaxis for SARS-CoV-2 infection. We report the case of a patient who developed COVID-19 while on hydroxychloroquine for mixed connectivitis associated with spondyloarthritis. Although more work is needed before any conclusions can be drawn, this raises questions about the protective role of this drug against infection. Are they really protected against COVID-19 or will they develop pauci-symptomatic forms? |Antirheumatic Agents/adverse effects/*therapeutic use[MESH] |Antiviral Agents/*therapeutic use[MESH] |Betacoronavirus/*drug effects[MESH] |COVID-19[MESH] |COVID-19 Drug Treatment[MESH] |Coronavirus Infections/complications/*drug therapy[MESH] |Disease Susceptibility[MESH] |Etanercept/adverse effects/*therapeutic use[MESH] |Humans[MESH] |Hydroxychloroquine/*therapeutic use[MESH] |Male[MESH] |Mixed Connective Tissue Disease/complications/*drug therapy[MESH] |Pandemics[MESH] |Pneumonia, Viral/complications/*drug therapy[MESH] |SARS-CoV-2[MESH] |Skin Diseases, Viral/*etiology[MESH] |Spondylarthropathies/complications/*drug therapy[MESH] |Tumor Necrosis Factor-alpha/adverse effects/*antagonists & inhibitors[MESH] |Urticaria/*etiology[MESH]Une infection par le SARS-CoV-2 chez un patient sous hydroxychloroquin(epmc).pdf DeepDyve Pubget Overpricing